Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease? (original) (raw)
The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease
Jozef Michalik
Journal of the neurological sciences, 2018
View PDFchevron_right
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients
Aristide Merola
Acta Neurologica Scandinavica, 2014
View PDFchevron_right
Levodopa-Induced Neuropathy: A Systematic Review
Aristide Merola
Movement Disorders Clinical Practice
View PDFchevron_right
Peripheral Polyneuropathy in Idiopathic Parkinson’s Disease with Oral Levodopa: Prevalence and Associated Factors
Jovany Medeiros
2017
View PDFchevron_right
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
L. Manfredi
Parkinsonism & Related Disorders, 2014
View PDFchevron_right
Prevalence of Levodopa-Induced Peripheral Neuropathy in Patients with Parkinson’s Disease and Vitamin B12 Defciency
Galen Medical Journal
Galen Medical Journal, 2021
View PDFchevron_right
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study
Aristide Merola
Movement Disorders, 2013
View PDFchevron_right
Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view
Jean-louis Montastruc, G. Durrieu, J. Sénard
Movement Disorders, 2010
View PDFchevron_right
Sensory Neuropathy in Parkinson Disease: Electrodiagnostic Evaluation
Otto Fustes
The Neurodiagnostic journal, 2020
View PDFchevron_right
Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation
mariachiara sensi
Acta Neurologica Scandinavica, 2017
View PDFchevron_right
Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT
Donald Grosset
Movement Disorders, 2006
View PDFchevron_right
Levodopa-induced dyskinesia in Parkinson disease
Jeremy Cutsforth-Gregory
Neurology, 2018
View PDFchevron_right
Kinetic-Dynamic Monitoring of Levetiracetam Effects in Patients With Parkinson Disease and Levodopa-Induced Dyskinesias
Manuela Contin
Clinical Neuropharmacology, 2007
View PDFchevron_right
Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert
Pablo Mir
Journal of Neurology, 2012
View PDFchevron_right
Postural Disorders and Antiparkinsonian Treatments in Parkinson Disease
Lucia Ameghino
Clinical Neuropharmacology, 2018
View PDFchevron_right
Profile of levodopa-induced dyskinesia in patients of Parkinson’s disease: a record based study
Pritikanta PAUL
Neurological Research, 2014
View PDFchevron_right
Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery
Angelo Antonini, Teus van Laar
Parkinsonism & Related Disorders, 2013
View PDFchevron_right
Large-Fiber Neuropathy in Parkinson’s Disease: Clinical, Biological, and Electroneurographic Assessment of a Romanian Cohort
Sebastian Pintea
Journal of Clinical Medicine
View PDFchevron_right
Postural Disorders and Antiparkinsonian Treatments in Parkinson Disease: An Exploratory Case-Control Study
Lucia Ameghino
Clinical Neuropharmacology, 2018
View PDFchevron_right
Central Levodopa Influx and the Clinical Motor Response to Levodopa in Patients With Parkinson Disease Complicated With Motor Fluctuations and Dyskinesias
María De Ceballos
Clinical Neuropharmacology, 2009
View PDFchevron_right
Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
Giovanni Cossu
Movement Disorders, 2009
View PDFchevron_right
Prevalence and factors associated with polyneuropathy in Parkinson’s disease
Raquel Alarcia
Basal Ganglia, 2016
View PDFchevron_right
A Prospective Study of the Drug Prescribing Rate and Pattern and Assessment of Adverse Drug Reactions in Patients with Idiopathic Parkinson Disease in a Tertiary Care Hospital
Am Jour of Phytomed & Clinical Therapeut
American Journal of Phytomedicine and Clinical Therapeutics (AJPCT), 2014
View PDFchevron_right
CASE REPORT: PHARMACOLOGICAL MANAGEMENT IN THE PATIENT WITH PARKINSON'S DISEASE (Atena Editora)
Atena Editora
CASE REPORT: PHARMACOLOGICAL MANAGEMENT IN THE PATIENT WITH PARKINSON'S DISEASE (Atena Editora), 2022
View PDFchevron_right
Emergencies in Parkinsonism
Adel Ekladious
Annals of clinical and medical case reports, 2022
View PDFchevron_right
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks
Taku Hatano
Parkinsonism & Related Disorders, 2013
View PDFchevron_right
Side effects induced by the acute levodopa challenge in Parkinson’s Disease and atypical parkinsonisms
Loredana Raciti
PLOS ONE
View PDFchevron_right
Drug-induced parkinsonism: prevalence, clinical features and follow-up study in three Sicilian communities
Giuseppe Salemi
Journal of Neurology, 1996
View PDFchevron_right
Treatment of Parkinsonian Features in Neurological Disorders Other than Parkinson’s Disease
Richard Peppard
Handbook of experimental pharmacology, 1989
View PDFchevron_right
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester
F. Stocchi
Journal of Neurology, 1996
View PDFchevron_right
Parkinsonism and Related Disorders
Carlo Alberto Artusi
2019
View PDFchevron_right
Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
Reeja Rajan
Annals of Indian Academy of Neurology, 2019
View PDFchevron_right
Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism
Don Gash
Movement Disorders, 1991
View PDFchevron_right
Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism
Wagner Horta
BMC Neurology, 2016
View PDFchevron_right
A case of drug induced dizziness in a patient on anti-Parkinson drugs
Rohit Singh
International Journal of Basic & Clinical Pharmacology
View PDFchevron_right